Averto Medical Secures $2.1 Million NIH Grant for Diverticulitis Therapy Advancement Averto Medical has garnered a significant $2.1 million grant from the NIH to enhance its innovative therapy targeting diverticulitis, promising new treatment options for patients.

Averto Medical Secures $2.1 Million NIH Grant for Diverticulitis Therapy Advancement #USA #San_Francisco #Averto_Medical #ColoSeal #Diverticulitis